Biomedical research, medical communication, oncology, neuroscience

RAMLA BENMAAMAR, Ph.D.

*-** **** ******, *** *V, Long Island City, 11109 New York

Cell: 212-***-**** e-mail: ********@*****.***

PhD in Pharmacology with experience writing and editing scientific and medical manuscripts, journal articles, grants proposals, abstracts, scientific posters and slide presentations. Versed in the analysis of scientific and clinical data, and presenting them in a clear, concise and understandable manner. Disease states experience includes oncology, neurology, dermatology, transplantations, COPD. Multilingual: English, French, Spanish, Italian, Arabic.

PROFESSIONAL EXPERIENCE

THE LANCET ONCOLOGY, London, UK • Sep 2012 – Present

High impact factor peer-reviewed medical journal that publishes original contributions aimed at advancing medical science and practice.

Freelance Writer

Regularly contribute to writing articles, on the latest clinical trials in oncology, for the News section of the journal.

Achievements:

Analysed original complex large study research papers, performed literature research on the subjects, contacted medical doctors for quotes to be included in the articles

Published several News articles in the News section of The Lancet Oncology

Phase Five Medical Communications, Grey Healthcare Group. New York, New York • Sep 2015 – Feb 2016

Associate Medical Director, Medical and Scientific Affairs

Develop clinical and scientific content for a full range of promotional medical education programs. Participate in discussions with clients regarding strategic planning and content development. Articulate tactical recommendations, clinical and therapeutic information in multiple therapeutic areas.

Achievements:

Developed content for educational programs and four advisory boards

Developed content for medical expert training

Performed clinical competitive intelligence at an international meeting

Synapse Medical Communications, LLC. New York, New York • April 2015 – Sep 2015

A leading health care marketing and medical communications company servicing the pharmaceutical, biotechnology, and medical device industries.

Associate Medical Director, Medical and Scientific Affairs

Develop clinical and scientific content for a full range of promotional medical education programs. Participate in discussions with clients regarding strategic planning and content development. Articulate tactical recommendations, clinical and therapeutic information in multiple therapeutic areas.

Achievements:

Performed clinical competitive intelligence work for two medical conferences and produced successful reports and executive summaries thereafter

Obtained acknowledgement and compliments by a KOL for educational/promotional content development for a speaker’s training program

Conducted presentations to the client and internally

Developed content for educational programs and advisory boards

NEW YORK UNIVERSITY LANGONE MEDICAL CENTER, New York, New York • June 2012 – July 2012

Renowned medical research institution, NYU Comprehensive Epilepsy Center is a leading centre for the development of new drugs, research and treatment of epilepsy and other neurological diseases.

Medical Writer

Participated in writing a medical review article on tuberous sclerosis and epilepsy.

Achievement:

Provided a well-written manuscript that served as a basis for the final article to be submitted for publication

UNITED NATIONS, New York, New York • Sep 2007 – April 2015

United Nations Headquarters, Department for General Assembly and Conference Management.

Meetings Coordinator

Manage and coordinate meetings such World Health Organization meetings and UNESCO meetings.

Achievements:

Provided outstanding level of communication and liaison with all parties including press, interpreters, diplomats and secretariat, researched and provided documents, contacted interpreters and press officers to communicate requirements and arrange for service availability

Promoted within 2 years due to initiative, work ethic and drive to achieve results

Additional promotions in 3rd and 5th years after proving ability to perform higher level of responsibilities of management

NEW YORK UNIVERSITY SCHOOL OF MEDICINE, New York, New York • Jan 2007 – Sep 2007

Skirball Institute for Biomolecular Medicine

Postdoctoral Research Scientist

Provided single labelling of glioblastoma brain tumour cells in cell culture and then in mice for MRI imaging. Assisted a technician in handling mice for surgery prior to imaging, and mentored the technician in cell culture techniques.

Achievements:

Quickly learned new field of research and analysed data critically to perform research, leading to innovative results that earned me a fellowship from The Gruson Fund for Brain Tumour Research and Care

Managed research project undertaken by technician

MOUNT SINAI SCHOOL OF MEDICINE, New York, New York • Aug 2005 – Nov 2006

Division of Hematology/Oncology, Department of Medicine

Postdoctoral Research Scientist

Studied cell degradation of a protein, SOD1, implicated in Multiple Sclerosis using molecular biology and cell culture techniques; mentored a technician to use these techniques.

Developed PowerPoint presentations of results for department meetings chaired by department head.

Achievements:

Learned new field of research, Multiple Sclerosis, and the proteins studied to elucidate their mechanisms and implications for the disease; introduced new technique to the lab that advanced the research undertaken

Rapid learning and application to research resulted in invitations to present findings at intra- and interdepartmental meetings

Innovative approach and excellent understanding of the field of research resulted in acknowledgement in an article published in a peer-reviewed journal

Participated in the screening and hiring of scientific candidates for jobs within the department

NEW YORK UNIVERSITY SCHOOL OF MEDICINE, New York, New York • Sep 2003 – Aug 2005

Department of Pathology

Postdoctoral Research Scientist

Investigated the degradation of a cell-cycle regulating protein, Cdh1, by employing molecular biology techniques, cell-culture techniques and biochemistry techniques. Mentored a Ph.D. student in the performance of experiments. Created PowerPoint presentations of research

results for journal clubs of research by peers.

Achievements:

Wrote a review paper encompassing cancer related research results, which necessitated extensive literature search. Thorough literature analysis, excellent writing and presentation resulted in the publication of the review paper in a high impact factor peer-reviewed journal

Collaborated with a Nobel Prize scientist. Quick understanding of his work and competence in performing experiments to advance his research earned acknowledgement in an article published in a peer-reviewed journal

Successfully published research results in a peer-reviewed journal as first author

Managed several scientific projects at the same time under tight deadlines, and collaborated with others on parallel research projects

EDUCATION

Ph.D. in Pharmacology

Université Louis Pasteur, Strasbourg, France (2003)

Master of Science, Cell Biology and Physiology

Université Louis Pasteur, Strasbourg, France (1999)

Bachelor of Biology

Université Louis Pasteur, Strasbourg, France (1998)

PROFESSIONAL ORGANIZATIONS

The New York Academy of Sciences

Biomed Experts

CERTIFICATION

International Conference on Harmonization – Good Clinical Practice Guideline Course (2010)

Royal Holloway, University of London, UK

ANNEX

PUBLICATIONS

Ramla Benmaamar

Federal Judge blocks 340B orphan drug exclusion

The Lancet Oncology, Vol. 15, Issue 8, Page e313

Ramla Benmaamar

Biomarker for fibrolamellar hepatocellular carcinoma

The Lancet Oncology, Vol. 15, Issue 4, Page e156

Ramla Benmaamar

Epigenetic modification boosts ovarian cancer vaccination

The Lancet Oncology, Vol. 15, Issue 2, Page e55

Ramla Benmaamar

Colorado: a first in the USA for legal sale of marijuana

The Lancet Oncology, Vol. 15, Issue 2, Page e55

Ramla Benmaamar

Targeted therapy outperforms chemotherapy in NSCLC

The Lancet Oncology, Vol. 14, Issue 8, Page e296

Ramla Benmaamar

Potential drug targets in acute myeloid leukaemia

The Lancet Oncology, Vol. 14, Issue 7, Page e259

Ramla Benmaamar

Non NF2 mutations in meningioma

The Lancet Oncology, Vol. 14, Issue 3, Page e91

Ramla Benmaamar

Promising drug in fight against advanced prostate cancer

The Lancet Oncology, Vol.14, Issue 1, Page e10

Ramla Benmaamar

Investigators ring the smoke alarm at US airports

The Lancet Oncology, Vol. 14, Issue 1, Page e7

Ramla Benmaamar

Peripheral-blood stem cells or bone marrow for leukaemia?

The Lancet Oncology, Vol. 13, Issue 12, Page e521

Ramla Benmaamar

Hope for personalised treatment of squamous-cell lung cancer.

The Lancet Oncology, Vol. 13, Issue 10, Page e416

Ramla Benmaamar, Michele Pagano

Involvement of the SCF complex in the degradation of Cdh1 in S-Phase

Cell Cycle 2005; 4(9): 1230-32

R. Benmaamar, C. Richichi, M. Gobbi, A.J. Daniels, A.G. Beck-Sickinger and A. Vezzani

Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats

Regulatory Peptides 2005; 125 (1-3): 79-83

Pagano M, Benmaamar R.

When protein destruction runs amok, malignancy is on the loose.

Cancer Cell 2003; 4(4): 251-6

Benmaamar R, Pham-Le BT, Marescaux C, Pedrazzini T, Depaulis A.

Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling.

Eur. J. Neurosci. 2003; 18(4): 768-74

Reibel S, Benmaamar R, Lê BT, Larmet Y, Kalra SP, Marescaux C, Depaulis A

Neuropeptide Y delays hippocampus kindling in the rat

Hippocampus 2003; 13(5): 557-60

Reibel S, Nadi S, Benmaamar R, Larmet Y, Carnahan J, Marescaux C, Depaulis A

Neuropeptide Y and epilepsy: varying effects according to seizure type and receptor activation

Peptides 2001; 22 (3): 529-39

BOOK CHAPTER

Cristina Richichi, Ramla Benmaamar, Marco Gobbi, En-Ju D. Lin, Matthew J. During, Gunther Sperk and Annamaria Vezzani

Neuropeptide Y and its receptors in Epileptogenesis, Neuropeptides in epileptogenesis

Kindling 6, 2005, Series: Advances in Behavioral Biology, Vol. 56, Corcoran, Michael E., Moshé, Solomon L. (Eds.)

PRESENTATIONS AT CONFERENCES

Forum of European Neuroscience (FENS), 2002, Paris, France, July 2002; Poster

presentation: “Neuropeptide Y5 receptor blockade inhibits limbic epileptogenesis”

Benmaamar R, Richichi C, M.Gobbi, Daniels A, Depaulis A, Vezzani A

6th International Neuropeptide Y Conference, Sydney, Australia, April 2001: Invited

Speaker: « Could Neuropeptide Y Y1 receptors initiate epileptogenesis? »

Benmaamar R, Pedrazzini T, Marescaux C, Depaulis A

Neurex Annual Meeting, Freibourg, Germany, Dec 2000; Poster presentation: “Role of Y1 receptors in the initiation of epileptogenesis in mice and rats ”

Benmaamar R, Pham B.T, Picaud S, Marescaux C, Depaulis A

American Society for Neuroscience (SFN) Meeting, New Orleans, USA, Nov 2000: Poster

presentation: « Role of Y1 receptors in the initiation of epileptogenesis in mice and rats »

Benmaamar R, Pham B.T, Picaud S, Marescaux C, Depaulis A

Neurex Annual Meeting, Basel, Switzerland, Dec1999 : Poster presentation: « Role of

Neuropeptide Y and Y1 receptors in the development of epileptogenesis in mice and rats. »

Benmaamar R, Reibel S, Palmiter R, Pedrazzini T, Marescaux C, Depaulis A

4eme Colloque de la Société des Neurosciences, Marseille, France, May 99: Poster

presentation: « Rôle du neuropeptide Y dans l’épileptogenèse chez la souris et le rat »

Benmaamar R, Reibel S, Lê B.T, Palmiter R.D, Marescaux C, Depaulis A

Regio-Neurex, Strasbourg, France, Dec 1998: Poster presentation: « Development of

hippocampus kindling in Neuropeptide Y knock-out mice »

Benmaamar R, Reibel S, Lê B.T, Hollopeter G, Marescaux C, Depaulis A

Contact this candidate